Scientific article
English

UHPLC-MS-based HDAC Assay Applied to Bio-guided Microfractionation of Fungal Extracts

Published in

Phytochemical analysis, vol. 28, no. 2, p. 93-100

Publication date

2017

Abstract

Histone deacetylases (HDAC) are considered as promising targets for cancer treatment. Today, four HDAC inhibitors, vorinostat, romidepsin, belinostat, and panobinostat, have been approved by the Food and Drug Administration (FDA) for cancer treatment, while others are in clinical trials. Among them, several are naturally occurring fungal metabolites.

Keywords

  • Chromatography
  • High Pressure Liquid/methods
  • Fungi/metabolism
  • Histone Deacetylases/metabolism
  • Tandem Mass Spectrometry/methods

Citation (ISO format)

ZWICK, Vincent et al. UHPLC-MS-based HDAC Assay Applied to Bio-guided Microfractionation of Fungal Extracts. In: Phytochemical analysis, 2017, vol. 28, n° 2, p. 93–100. doi: 10.1002/pca.2652

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0958-0344
533views
3downloads

Technical informations

Creation

13/06/2017 23:04:00

First validation

13/06/2017 23:04:00

Update

15/03/2023 01:47:28

Status update

15/03/2023 01:47:27

Last indexation

31/10/2024 07:12:42
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated